UNSECURED PROMISSORY NOTEUnsecured Promissory Note • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • California
FOR VALUE RECEIVED, the undersigned, ADITX THERAPEUTICS, INC., a Delaware corporation (together with its successors and assigns, the “Borrower”), hereby promises to pay to the order of ________________, an individual (together with his successors and assigns, the “Lender”), at the Lender’s offices at ___________ (or such other place as the Lender may designate in writing to the Borrower), the aggregate principal sum of _______($____), with interest, upon the terms and subject to the conditions of this unsecured promissory note (the “Note”) as set forth below. The Lender and Borrower collectively shall be referred to as the “Parties.”
ContractCommon Stock Purchase Warrant • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS WARRANT AND THE SHARES OF COMMON STOCK PURCHASABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH WARRANTS AND SHARES MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.
PATENT & TECHNOLOGY LICENSE AGREEMENTPatent & Technology License Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • California
This Patent and Technology License Agreement (“Agreement”) is effective on March 15, 2018 (the “Effective Date”) and is entered by and between Loma Linda University (“LLU”), a California Religious Institution, whose address is 24887 Taylor Street, Suite 201, Loma Linda, California 92354, and ADiTx Therapeutics, Inc., a Delaware C Corporation, with its principal place of business at 11161 Anderson St., Suite 105-10014, Loma Linda, CA 92354 (“Licensee”) (collectively, “Parties”, or singly, “Party”).
CONSULTING AGREEMENTConsulting Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • Maryland
This consulting agreement (“Agreement”) is effective as of March 1, 2018 by and between ADiTx Therapeutics, Inc. (“Client”) and Canyon Ridge Development LLC doing business as Mission Critical Solutions International (“Consultant”). Client and Consultant together may be referred to hereunder as the “Parties”.
NOTE PURCHASE AGREEMENTNote Purchase Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Note Purchase Agreement (this “Agreement”) is dated as of ______________ by and between Aditx Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchaser identified on the signature pages hereto (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of [_______], 2019 between Aditx Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July ___, 2018 between ADITX THERAPEUTICS, INC., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXCLUSIVE LICENSE AGREEMENT WITH EQUITYExclusive License Agreement • May 14th, 2020 • ADiTx Therapeutics, Inc. • Pharmaceutical preparations • California
This Agreement between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (“Stanford”), an institution of higher education having powers under the laws of the State of California, and Aditx Therapeutics, Inc. (“Aditxt”), a corporation having a principal place of business at 11161 Anderson St., Suite 105-10014, Loma Linda, CA 92354, is effective on the 3rd day of February, 2020 (“Effective Date”).
